EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Generation of two induced pluripotent stem cell lines (HIMRi006-A and HIMRi007-A) from Pompe patients with infantile and late disease onset

L Volke, N M Daya, K Döring, M Rohm, M Athamneh, H Zaehres, A Roos, A K Güttsches, L Mavrommatis, M Vorgerd

Stem Cell Research · 2024

DOI: 10.1016/j.scr.2024.103459 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cell Research, 2024. Verfasst von L Volke und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Heimer Institute for Muscle Research, BG-University Hospital Bergmannsheil, Ruhr-University Bochum, 44789 Bochum, Germany. Hauptthemen laut MEDLINE: Glycogen Storage Disease Type II, Kruppel-Like Factor 4, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Ruhr-Universität Bochum.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Here we present the generation of HIMRi006-A and HIMRi007-A Pompe disease (PD) patient derived human induced pluripotent stem cell (hiPSC) lines. HIMRi006-A represents an infantile onset disease (IOPD) phenotype caused by a homozygous c.307 T > G mutation in the GAA gene. HIMRi007-A is characterized by heterozygous mutations c.-32-13 T > G/c.1716C > G and is associated with an adult onset of disease symptoms (LOPD). Both lines are generated via lentiviral expression of OCT4, SOX2, KLF4, and c-MYC. The lines display a typical embryonic stem cell morphology, express pluripotency markers, retain a normal karyotype (46, XX/XY) and have the differentiation capacity in all three germ layers. Altogether, both lines provide a resource tool to the community for future in depth molecular studies of PD pathomechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycogen Storage Disease Type IIKruppel-Like Factor 4Induced Pluripotent Stem CellsHumansCell DifferentiationCell LineMaleInfantMutationFemale

Substanzen

Kruppel-Like Factor 4KLF4 protein, human

Autor:innen und Institutionen

  • Department of Neurology, Heimer Institute for Muscle Research, BG-University Hospital Bergmannsheil, Ruhr-University Bochum, 44789 Bochum, Germany.
  • Department of Human Genetics, Ruhr-University Bochum, 44801 Bochum, Germany.
  • Department of Clinical Sciences, Faculty of Medicine, Yarmouk University, Irbid, Jordan.
  • Department of Anatomy and Molecular Embryology, Institute of Anatomy, Ruhr-University Bochum, 44801 Bochum, Germany.

Förderung

  • Deutsche Forschungsgemeinschaft
  • Ruhr-Universität Bochum

Zitieren

APA

Volke, L., Daya, N. M., Döring, K., Rohm, M., Athamneh, M., Zaehres, H., Roos, A., Güttsches, A. K., Mavrommatis, L., & Vorgerd, M. (2024). Generation of two induced pluripotent stem cell lines (HIMRi006-A and HIMRi007-A) from Pompe patients with infantile and late disease onset. Stem Cell Research. https://doi.org/10.1016/j.scr.2024.103459

Vancouver

Volke L, Daya NM, Döring K, Rohm M, Athamneh M, Zaehres H, et al. Generation of two induced pluripotent stem cell lines (HIMRi006-A and HIMRi007-A) from Pompe patients with infantile and late disease onset. Stem Cell Research. 2024. doi:10.1016/j.scr.2024.103459

BibTeX
@article{Volke2024,
  author = {Volke, L and Daya, N M and Döring, K and Rohm, M and Athamneh, M and Zaehres, H and Roos, A and Güttsches, A K and Mavrommatis, L and Vorgerd, M},
  title = {Generation of two induced pluripotent stem cell lines (HIMRi006-A and HIMRi007-A) from Pompe patients with infantile and late disease onset},
  journal = {Stem Cell Research},
  year = {2024},
  doi = {10.1016/j.scr.2024.103459}
}
Kostenlos starten →